A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes

European Journal of Immunology

Volumn 29, Issue 10, 1999, Pages 3329-3337

  Duffour, Marie Thérèse ^a   Chaux, Pascal ^a   Lurquin, Christophe ^a   Cornelis, Guy ^b   Boon, Thierry ^a   Van Der Bruggen, Pierre ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b Institute of Cellular Pathology   (Belgium)

Author keywords

Adenovirus; Antigen; Cytotoxic T lymphocyte; MAGE; Tumor

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; PEPTIDE; TUMOR ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; ASIAN; CANCER IMMUNOTHERAPY; CAUCASIAN; CELL CULTURE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; LUNG CARCINOMA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VACCINIA; YERSINIA ENTEROCOLITICA;

ADENOVIRIDAE; ANIMALS; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; COS CELLS; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; HLA-A2 ANTIGEN; LYMPHOCYTE ACTIVATION; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032842891     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199910)29:10<3329::AID-IMMU3329>3.0.CO;2-7     Document Type: Article

References (46)

1. Hérin, M., Lemoine, C., Weynants, P., Vessière, F., Van Pel, A., Knuth, A., Devos, R. and Boon, T., Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer 1987. 39: 390-396.
2. Anichini, A., Fossati, G. and Parmiani, G., Clonal analysis of the cylolytic T-cell response to human tumors. Immunol. Today 1987. 8: 385-389.
3. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991. 254: 1643-1647.
4. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W. and Boon, T., Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994. 40: 360-369.
5. Lucas, S., De Smet, C., Arden, K. C., Viars, C. S., Lethé, B., Lurquin, C. and Boon, T., Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 1998. 58: 743-752.
6. Lurquin, C., De Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P. and Boon, T., Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumors of various histological origins. Genomics 1997. 46: 397-408.
7. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N. and Monaco, A. P., Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA 1995. 92: 4987-4991.
8. Haas, G. G., Jr., D'Cruz, O. J. and De Bault, L. E., Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am. J. Reprod. Immunol. Microbiol. 1988. 18: 47-51.
9. Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M. and Itoh, K., Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 1995. 55: 3478-3482.
10. De Plaen, E., Naerhuyzen, B., De Smet, C., Szikora, J.-P. and Boon, T., Alternative promoters of gene MAGE4a. Genomics 1997. 40: 305-313.
11. Hunt, J. S., Immunobiology of pregnancy. Curr. Opin. Immunol. 1992. 4: 591-596.
12. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C. and Mellor, A. L., Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998. 281: 1191-1193.
13. Jung, s. and Schluesener, H. J., Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 1991. 173: 273-276.
14. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A. and Serra, H. M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 1994. 91: 2105-2109.
15. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A. and Boon, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 1994. 24: 3038-3043.
16. Herman, J., van der Bruggen, P., Luescher, I., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T. and Coulie, P. G., A peptide encoded by the human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics 1996. 43: 377-383.
17. Fleischhauer, K., Gattinoni, L., Dalerba, P., Lauvau, G., Zanaria, E., Dabovic, B., van Endert, P., Bordignon, C. and Traversari, C., The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes. Cancer Res. 1998. 58: 2969-2972.
18. Purcell, A. W., Chen, W., Ede, N. J., Gorman, J. J., Fecondo, J. V., Jackson, D. C., Zhao, Y. and McCluskey, J., Avoidance of self-reactivity results in skewed CTL responses to rare components of synthetic immunogens. J. Immunol. 1998. 160: 1085-1090.
19. Van den Eynde, B. and van der Bruggen, P., T cell-defined tumor antigens. Curr. Opin. Immunol. 1997. 9: 684-693.
20. Steinman, R., The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991. 9: 271-296.
21. Arthur, J., Butterfield, L., Roth, M., Bui, L., Kiertscher, S., Lau, R., Dubinett, S., Glaspy, J., McBride, W. and Economou, J., A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 1997. 4: 17-25.
22. Kim, C., Prevette, T., Cormier, J., Overwijk, W., Roden, M., Restifo, N., Rosenberg, S. and Marincola, P.M., Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro. J. Immunother. 1997. 20: 276-286.
23. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M. and Schuler, G., Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994. 180: 83-93.
24. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 1994. 179: 1109-1118.
25. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. and Enk, A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 3135-3142.
26. Rammensee, H.-G., Bachmann, J. and Stevanovic, S. (Eds.) MHC Ligands and Peptide Motifs. Springer, Berlin 1997.
27. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., van Pel, A., De Plaen, E., Amar-Costesec, A. and Boon, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 1992. 176: 1453-1457.
28. van der Bruggen, P., Szikora, J.-P., Boël, P., Wildmann, C., Somville, M., Sensi, M. and Boon, T., Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol. 1994. 24: 2134-2140.
29. Huang, L.-Q., Brasseur, F., Serrano, A., De Plaen, E., van der Bruggen, P., Boon, T. and Van Pel, A., Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J. Immunol. 1999. 162: 6849-6854.
30. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F. and Boon, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 1994. 179: 921-930.
31. Valmori, D., Gileadi, U., Servis, C., Dunbar, P. R., Cerottini, J.-C., Romero, P., Cerundolo, V. and Levy, F., Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 1999. 189: 895-906.
32. Takaki, T., Hiraki, A., Uenaka, A., Gomi, S., Itoh, K., Udono, H., Shibuya, A., Tsuji, T., Sekiguchi, S. and Nakayama, E., Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes. Int. J. Oncol. 1998. 12: 1103-1109.
33. Tanaka, F., Fujie, T., Go, H., Baba, K., Mori, M., Takesako, K. and Akiyoshi, T., Efficient induction of antitumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol. Immunother. 1997. 44: 21-26.
34. Shichijo, S., Hayashi, A., Takamori, S., Tsunosue, R., Hoshino, R., Sakata, M., Kuramoto, T., Oizumi, K. and Itoh, K., Detection of MAGE-4 protein in lung cancers. Int. J. Cancer 1995. 64: 158-165.
35. Iwamoto, O., Nagao, Y., Shichijo, S., Eura, M., Kameyama, T. and Itoh, K., Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma. Int. J. Cancer 1997. 70: 287-290.
36. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
37. Romero, P., Rod Dunbar, P., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J. L., Lienard, D., Cerottini, J. C. and Cerundolo, V., Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 1998. 188: 1641-1650.
38. Carney, D. N., Bunn, P. A., Gazdar, A. F., Pagan, J. A. and Minna, J. D., Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc. Natl. Acad. Sci. USA 1981. 78: 3185-3189.
39. Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M. and Briand, P., Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 1992. 90: 626-630.
40. Sory, M. P. and Cornelis, G. R., Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 1994. 14: 583-594.
41. Cornelis, G. R., The Yersinia deadly kiss. J. Bacteriol. 1998. 180: 5495-5504.
42. Boland, A. and Cornells, G. R., Role of YopP in suppression of Tumor Necrosis Factor alpha release by macrophages during Yersinia infection. Infect. Immun. 1998. 66: 1878-1884.
43. Neyt, C., Iriarte, M., Ha Thi, V. and Cornelis, G. R., Virulence and arsenic resistance in Yersiniae. J. Bacteriol. 1997. 179: 612-619.
44. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L. and Boon, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992. 35: 145-152.
45. Espevik, T. and Nissen-Meyer, J., A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 1986. 95: 99-105.
46. Hansen, M. B., Nielsen, S. E. and Berg, K., Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989. 119: 203-210.